Jingyuan Wen
Jingyuan Wen is a New Zealand pharmacology academic, and is a full professor at the University of Auckland, specialising in drug discovery, formulation and delivery.
Academic career
Wen completed a Doctor of Medicine degree at Changchun University of Chinese Medicine, and a Master of Science degree at Fudan University. She completed her PhD titled Barriers to the intestinal absorption of peptides and proteins in the possum at the University of Otago, under the supervision of Professor Ian Tucker. After postdoctoral research, Wen then joined the faculty of the University of Auckland, rising to full professor in 2024. Wen is an associate investigator with the Maurice Wilkins Centre for Molecular Biodiscovery, a Centre of Research Excellence. She has been active in the New Zealand chapter of the Controlled Release Society, and has been an invited speaker at the annual meeting of the international society, and Chair of the Oral Drug Delivery Award Committee. She is an editor for the journals Acta Materia Medica, Journal of Pharmaceutics and the Asian Journal of Pharmaceutical Science.Wen's research focuses on drug discovery, formulation, and delivery systems. Wen has received research funding from the NZ-China Biomedical Research Alliance fund of the Health Research Council-administered MBIE Catalyst Fund, to work with Guo-Liang Lu and William Denny on Chinese collaboration to investigate lymphocyte infiltration using nanosystems. She has also worked with Craig Bunt on diabetes treatments.